BUZZ-Ardent Health shares fall after launching secondary public offering
路透社2026/11/18 01:47Updated content to reflect the company's corrected press release regarding the sale of shareholder holdings.
November 18 - ** Hospital operator Ardent Health (ARDT.N) fell 14.9% to $15.10 in after-hours trading following news of a secondary offering.
** ARDT (link) is launching an 8 million share offering; Equity Group Investments (affiliate EGI) will sell approximately 7.1 million shares, and a Ventas VTR.N affiliate will sell 863,281 shares.
** Additionally, as part of this offering, ARDT plans to repurchase up to 1.5 million shares from the underwriters.
** The offering is led by JPMorgan and Barclays, with seven additional joint bookrunners participating.
** According to the prospectus, EGI-AM Investments currently holds a 54.8% stake in ARDT, and Ventas holds 6.6% (link).
** Brentwood, Tennessee-based ARDT currently has about 140.9 million shares outstanding.
** At Tuesday's close, the stock fell 1.9% to $17.75; shares have jumped 47.5% in November and have nearly doubled year-to-date.
** According to LSEG data, the average rating from 13 analysts is “buy”; the median price target has been raised to $18 from $13 a month ago.
(To facilitate non-English speakers, Reuters has automated its coverage into several other languages. Since automated translation may contain errors or lack necessary context, Reuters does not guarantee the accuracy of the automated translation text, which is provided for readers’ convenience only. Reuters accepts no responsibility for any damage or loss caused by use of the automated translation feature.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Japanese Yen finds support as intervention risks linger near 160.00


Anthropic IPO sees overwhelming demand! Report: Subscription approaches $500 billions, considering increasing fundraising size
According to reports from U.S. media, institutional investor subscription demand for Anthropic has reached approximately 400 billions, while retail investor demand is close to 100 billions. Driven by demand far exceeding expectations, Anthropic is considering raising the pricing above $80 and increasing the number of shares issued.